Suicide and drug toxicity mortality in the first year of the COVID-19 pandemic: use of medical examiner data for public health in Nova ScotiaCOVID-19 대유행 첫 해의 자살 및 약물 독성 사망률: 노바스코샤의 공중 보건을 위한 검시관 데이터 사용Article Published on 2022-02-162022-09-11 Journal: Health promotion and chronic disease prevention in [Category] COVID19(2023년), SARS, 치료기술, [키워드] applied cause cause of death change Characteristics collaboration coroners COVID-19 COVID-19 pandemic death diver drug overdose drug toxicity engage English examiner expected Factors French instance Manner of death medical examiner medical examiners mental illness Mortality nous Nova overdose pandemic première processus public health public health surveillance raised reduction reduction in remained response risk risk ratio service Suicide Suicide. Surveillance TEMPS Toxicity [DOI] 10.24095/hpcdp.42.2.02 PMC 바로가기 [Article Type] Article
SARS-CoV-2 seroprevalence among blood donors in Québec, and analysis of symptoms associated with seropositivity: a nested case-control studyQuébec의 헌혈자 사이의 SARS-CoV-2 혈청 유병률 및 혈청 양성과 관련된 증상 분석: 중첩 사례-대조군 연구Article Published on 2021-08-012022-09-11 Journal: Canadian Journal of Public Health = Revue Canadien [Category] MERS, SARS, 진단, 치료기술, [키워드] 95% CI Analysis antibody association Asymptomatic blood donor Blood donors blood sample case-control study collected control group COVID-19 COVID-19 symptoms cross-sectional Donor donors eligible ELISA ELISA RBD English escaped evaluate except for First wave French healthy blood donor healthy blood donors individual infected with SARS-CoV-2 Infection less occurrence of COVID-19 pandemic Participation première proportion RBD Receptor binding domain reported residual RéSUMé rhinorrhea SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 seroprevalence serological survey seronegative Seropositivity Seroprevalence SIGN significantly Signs and symptoms Signs and symptoms. SRAS-CoV-2 Study design Symptom Symptoms tested Univariate analysis vaccination [DOI] 10.17269/s41997-021-00531-6 PMC 바로가기 [Article Type] Article